共 50 条
Heart failure highlights in 2011
被引:2
|作者:
Westenbrink, B. Daan
[1
]
Damman, Kevin
[1
]
Rienstra, Michiel
[1
]
Maass, Alexander H.
[1
]
van der Meer, Peter
[1
]
机构:
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9700 RB Groningen, Netherlands
关键词:
CARDIAC RESYNCHRONIZATION THERAPY;
VENTRICULAR EJECTION FRACTION;
IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR;
CELL DISTRIBUTION WIDTH;
GLYCATION END-PRODUCTS;
ATRIAL-FIBRILLATION;
DIASTOLIC DYSFUNCTION;
NATRIURETIC PEPTIDE;
MITRAL REGURGITATION;
DIABETES-MELLITUS;
D O I:
10.1093/eurjhf/hfs121
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Heart failure (HF) remains a major medical problem, and the European Journal of Heart Failure is dedicated to publishing research further investigating its pathophysiology and diagnosis in order to help clinicians alleviate symptoms and improve patient outcomes.(1) This review reports on important studies in the field of HF published in 2011. All research areas are addressed, including experimental studies, biomarkers, clinical trials, arrhythmias, and new insights into the role of device therapy.
引用
收藏
页码:1090 / 1096
页数:7
相关论文